Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Dibasic Sodium Phosphate, Anhydrous
2. Disodium Acid Phosphate
3. Disodium Hydrogen Phosphate
4. Disodium Hydrogen Phosphate Anhydrous
5. Monosodium Dihydrogen Phosphate
6. Neutral Sodium Hydrogen Phosphate
7. Phosphoric Acid, Disodium Salt
8. Phosphoric Acid, Disodium Salt, 32p-labeled
9. Phosphoric Acid, Disodium Salt, Anhydrous
10. Phosphoric Acid, Disodium Salt, Dodecahydrate
11. Phosphoric Acid, Disodium Salt, Heptahydrate
12. Phosphoric Acid, Monosodium Salt
13. Phosphoric Acid, Monosodium Salt, Anhydrous
14. Phosphoric Acid, Sodium (2:3) Salt
15. Phosphoric Acid, Sodium Salt
16. Phosphoric Acid, Trisodium Salt
17. Phosphoric Acid, Trisodium Salt , 32p-labeled
18. Phosphoric Acid, Trisodium Salt , Dodecahydrate
19. Sodium Biphosphate
20. Sodium Dihydrogen Orthophosphate
21. Sodium Dihydrogen Phosphate
22. Sodium Hydrophosphate
23. Sodium Phosphate
24. Sodium Phosphate Monobasic Anhydrous
25. Sodium Phosphate, Dibasic
26. Sodium Phosphate, Dibasic (anhydrous)
27. Sodium Phosphate, Disodium Salt
28. Sodium Phosphate, Monobasic
29. Sodium Phosphate, Monobasic Anhydrous
30. Sodium Phosphate, Tribasic
31. Sodium Phosphate, Tribasic, Dodecahydrate
32. Trisodium Phosphate
33. Trisodium Phosphate Dodecahydrate
1. 10039-32-4
2. Sodium Hydrogenphosphate Dodecahydrate
3. Disodium Hydrogen Phosphate Dodecahydrate
4. Phosphoric Acid, Disodium Salt, Dodecahydrate
5. Sodium Phosphate Dibasic Dodecahydrate
6. Disodium Orthophosphate, Dodecahydrate
7. Sodium Phosphate, Dibasic, Dodecahydrate
8. Disodium;hydrogen Phosphate;dodecahydrate
9. Disodium Hydrogen Phosphate, Dodecahydrate
10. Disodium Phosphate 12 Hydrate
11. E1w4n241fo
12. Disodium Hydrogenphosphate Dodecahydrate
13. Sodium Monohydrogen Phosphate Dodecahydrate
14. Di-sodium Hydrogen Phosphate Dodecahydrate
15. Unii-e1w4n241fo
16. Sodium Monohydrogen Phosphate Dodecahydrate (2:1:1:12)
17. Sodium Hydrogen Phosphate Dodecahydrate
18. Disodiumphosphatedodecahydrate
19. Dtxsid4064923
20. Chebi:91259
21. Dibasic Dodecahydratesodium Phosphate
22. Mfcd00149181
23. Akos015950614
24. Dibasic Sodium Phosphate Hydrate
25. Dibasic Sodium Phosphate Hydrate (jp17)
26. Monosodium Phosphate Dodecahydrate
27. Sodium Hydrogen Phosphate--water (1/12)
28. Phosphoric Acid, Disodiumsalt, Dodecahydrate
29. Disodium Phosphate (na2hpo4.12h2o)
30. Ft-0625318
31. Dibasic Sodium Phosphate Hydrate [jan]
32. Dibasic Sodium Phosphate, Dodecahydrate
33. Sodium Phosphate, Dibasic Dodecahydrate
34. D06389
35. Sodium Phosphate (na2hpo4) Dodecahydrate
36. Disodium Phosphate (na2hpo4) Dodecahydrate
37. Disodium Hydrogen Orthophosphate Dodecahydrate
38. J-000126
39. Monohydrogen Disodium Phosphate Dodecahydrate
40. Sodium Phosphate, Dibasic Dodecahydrate [mi]
41. Disodium Phosphate Dodecahydrate [ep Impurity]
42. Disodium Phosphate Dodecahydrate [ep Monograph]
43. Q27163167
44. Sodium Phosphate Dibasic Dodecahydrate [who-dd]
45. Sodium Phosphate, Dibasic, Dodecahydrate [ii]
46. Disodium Phosphate Dodecahydrate (na2hpo4.12h2o)
| Molecular Weight | 358.14 g/mol |
|---|---|
| Molecular Formula | H25Na2O16P |
| Hydrogen Bond Donor Count | 13 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 0 |
| Exact Mass | 358.06756027 g/mol |
| Monoisotopic Mass | 358.06756027 g/mol |
| Topological Polar Surface Area | 95.4 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 46.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 15 |
ABOUT THIS PAGE
23
PharmaCompass offers a list of 10039-32-4 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right 10039-32-4 manufacturer or 10039-32-4 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred 10039-32-4 manufacturer or 10039-32-4 supplier.
PharmaCompass also assists you with knowing the 10039-32-4 API Price utilized in the formulation of products. 10039-32-4 API Price is not always fixed or binding as the 10039-32-4 Price is obtained through a variety of data sources. The 10039-32-4 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 10039-32-4 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 10039-32-4, including repackagers and relabelers. The FDA regulates 10039-32-4 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 10039-32-4 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 10039-32-4 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 10039-32-4 supplier is an individual or a company that provides 10039-32-4 active pharmaceutical ingredient (API) or 10039-32-4 finished formulations upon request. The 10039-32-4 suppliers may include 10039-32-4 API manufacturers, exporters, distributors and traders.
click here to find a list of 10039-32-4 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
10039-32-4 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 10039-32-4 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 10039-32-4 GMP manufacturer or 10039-32-4 GMP API supplier for your needs.
A 10039-32-4 CoA (Certificate of Analysis) is a formal document that attests to 10039-32-4's compliance with 10039-32-4 specifications and serves as a tool for batch-level quality control.
10039-32-4 CoA mostly includes findings from lab analyses of a specific batch. For each 10039-32-4 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
10039-32-4 may be tested according to a variety of international standards, such as European Pharmacopoeia (10039-32-4 EP), 10039-32-4 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (10039-32-4 USP).
